Greenwich LifeSciences, Inc.

Ownership Transactions Reported by 6 Insiders

Symbol
GLSI on Nasdaq
Industry
Pharmaceutical Preparations
Location
3992 Bluebonnet Dr, Building 14, Stafford, TX

Insiders trading volume in the past year

Greenwich LifeSciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Snehal Patel CEO and CFO, Director, 10%+ Owner $46.8M +$515K +1.11% Nov 25, 2025
Jaye Thompson VP Clinical Reg Affairs $3.41M Dec 24, 2024
David McWilliams Director Dec 24, 2024
Eric Rothe Director Dec 24, 2024
Frank Daugherty Chief Medical Officer, Director Dec 24, 2024
Kenneth Hallock Director Dec 24, 2024

Recent Insider Transactions by Companies or Individuals for Greenwich LifeSciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.